Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Regulatory News (SPH)

  • There is currently no data for SPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Sinclair Pharma Plc

2 Nov 2018 12:00

RNS Number : 1642G
Peel Hunt LLP
02 November 2018
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Peel Hunt LLP

(b) Name of offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Sinclair Pharma Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Sinclair Pharma Plc

(d) Date dealing undertaken:

01 November 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

 

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary Shares

Buy

94

31.81 GBx

31.81 GBx

Ordinary Shares

Sell

79,464

31.80 GBx

31.80 GBx

 

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

02 November 2018

Contact name:

Kathleen Lloyd

Telephone number:

0207 418 8911

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERFKBDNOBDKFDK
Date   Source Headline
4th Feb 20169:10 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
3rd Feb 20163:23 pmRNSForm 8.3 - [Sinclair Pharma plc]
3rd Feb 20169:26 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
2nd Feb 20163:16 pmRNSForm 8.3 - [Sinclair Pharma plc]
2nd Feb 20168:08 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
1st Feb 20163:03 pmRNSForm 8.3 - [Sinclair Pharma plc]
1st Feb 20168:33 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
29th Jan 20163:16 pmRNSForm 8.3 - [Sinclair Pharma plc]
29th Jan 20168:39 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
28th Jan 20169:04 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
27th Jan 20169:01 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
26th Jan 20161:45 pmRNSForm 8.3 - [Sinclair Pharma plc]
26th Jan 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
25th Jan 20162:13 pmRNSForm 8.3 - [Sinclair Pharma plc]
25th Jan 201611:50 amRNSResult of AGM
25th Jan 20169:18 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
22nd Jan 20163:05 pmRNSForm 8.3 - [Sinclair Pharma plc]
22nd Jan 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
21st Jan 20163:20 pmRNSForm 8.3 - [Sinclair Pharma plc]
21st Jan 201611:45 amBUSForm 8.3 - Sinclair Pharma Plc
21st Jan 20169:22 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
21st Jan 20169:15 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma - Replacement
20th Jan 20161:38 pmRNSForm 8.3 - Sinclair Pharma plc
20th Jan 201612:44 pmRNSForm 8.3 - [Sinclair Pharma plc]
20th Jan 20168:27 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
19th Jan 201612:38 pmRNSForm 8.3 - [Sinclair Pharma plc]
19th Jan 201611:48 amBUSForm 8.3 - Sinclair Pharma Plc
19th Jan 20168:15 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
18th Jan 20163:17 pmRNSForm 8.3 - [Sinclair Pharma plc]
18th Jan 20169:23 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
14th Jan 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
13th Jan 20163:16 pmRNSForm 8.3 - [Sinclair Pharma plc]
13th Jan 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
12th Jan 20163:12 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
12th Jan 20163:03 pmRNSForm 8.3 - [Sinclair Pharma plc]
12th Jan 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair IS Pharma PLC
11th Jan 20163:09 pmRNSForm 8.3 - [Sinclair Pharma plc]
11th Jan 201611:50 amRNSForm 8.5 (EPT/RI) - Sinclair IS Pharma PLC
11th Jan 201611:29 amRNSForm 8.3 - Sinclair Pharma plc
8th Jan 20162:57 pmRNSForm 8.3 - [Sinclair Pharma plc]
8th Jan 20162:53 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
8th Jan 201612:46 pmRNSForm 8.3 - Sinclair Pharma plc
8th Jan 20169:55 amRNSForm 8.5 (EPT/RI) - Sinclair IS Pharma PLC
7th Jan 20163:14 pmRNSForm 8.3 - [Sinclair Pharma plc]
7th Jan 201611:34 amRNSForm 8.3 - Sinclair Pharma plc
7th Jan 20168:41 amRNSForm 8.5 (EPT/RI) - Sinclair IS Pharma PLC
6th Jan 20162:21 pmRNSForm 8.3 - Sinclair Pharma plc
6th Jan 20168:38 amRNSForm 8.5 (EPT/RI) - Sinclair IS Pharma PLC
5th Jan 20162:40 pmRNSForm 8.3 - Sinclair Pharma plc
5th Jan 20169:06 amRNSForm 8.5 (EPT/RI) - Sinclair IS Pharma PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.